Pathway Health (TSX-V:PHC) Corp said its shares began trading today (December 17) on the Frankfurt Stock Exchange (FSE).
"Listing on the Frankfurt Stock Exchange will provide Pathway Health with direct access to the European capital markets and an opportunity for the company to increase trading liquidity and facilitate investment by expanding our shareholder base," said Ken Yoon, CEO of Pathway Health in a brief statement.
The integrated healthcare company began trading on the German exchange under the symbol 'KL1'.
READ: Pathway Health anticipates new pharmacy contracts for medical cannabis in 2022 as it prepares for Cannabis 3.0
Pathway Health (TSX-V:PHC) owns and operates nine community-based clinics across four provinces where its team of health professionals work together to help patients through a variety of evidence-based approaches and products, including medical cannabis.
The company is the leading provider of medical cannabis services in Canada and has established itself as the leading partner with national and regional pharmacy companies for the delivery of medical cannabis services to their customers.
The company is working with several pharmacy companies on the development of Cannabis Health Products (CHPs) for OTC product distribution through retail pharmacy locations across the country following anticipated changes to the Cannabis Act.
Contact the author at giles@proactiveinvestors.com